International Journal of Clinical Research

Objective To discuss and study the effect of atorvastatin combined with trimetazidine in the treatment of coronary heart disease and clarify the pharmaceutical content. Methods A total of 100 patients admitted from January 2024 to December 2024 participated in the study and were randomly divided into a control group and an experimental group, with 50 cases in each group. The control group was treated with trimetazidine, and the experimental group was treated with atorvastatin combined with trimetazidine. The comparison was as follows: treatment effect; blood lipid index and cardiac function index. Results After the two groups of patients were treated with different schemes, the treatment effect of the experimental group was better than that of the control group, p<0.05. The blood lipid index of the patients was compared, and the blood lipid index of the experimental group was better than that of the control group, p<0.05. The cardiac function index of the patients was evaluated, and the experimental group was better than the control group, p<0.05. Conclusion Providing atorvastatin combined with trimetazidine to patients with coronary heart disease can improve the treatment effect, improve blood lipids, improve heart function, and increase recovery speed.

Atorvastatin; Trimetazidine; Coronary heart disease; Clinical efficacy; Pharmacy